In the recent ASCO and EHA meetings several important abstracts were presented regarding the treatment and management of multiple myeloma.
Treatment of new diagnosed myeloma patients
Updates in the treatment of patients with high risk myeloma
Evaluation of response to therapy and the critical role of MRD and new approaches to imaging
Treatment of patients with relapsed or refractory myeloma
T-cell redirecting therapies for multiple myeloma treatment
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.